UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 15, 2024
Accession Number:
0001140361-24-043036
Submission Type:
POS AM
CIK:
0001444192
Company Name:
Acasti Pharma Inc.
File Number:
333-280536